Biogen Idec Inc. (BIIB), Celgene Corporation (CELG), Gilead Sciences, Inc. (GILD): 3 of Biotech’s Best

Page 1 of 2

It’s been a healthy year-to-date for the biotech sector, with the space logging huge gains above and beyond those of the broad based market. Industry companies have thrived thanks to technological advances that facilitated new discoveries and stoked greater demand for life-enhancing and lifesaving products.

Industry research firm IBIS World estimates global biotechnology industry revenue will jump 12.7% in 2013, reaching $262 billion. That follows an average annual growth rate of 11% over the last five years.

Moreover, the industry is still in the growth stage of its life cycle. Constant technological findings, an insatiable appetite for new and better drugs, and the explosive growth of emerging markets will influence and fuel the industry. Let’s take a closer look at three of biotech’s best.

One of the biggest

Biogen Idec Inc (NASDAQ:BIIB)

Biogen Idec Inc. (NASDAQ:BIIB), one of the biggest and best-known names in the biotech sector, is up some 40% since the start of 2013, and a whopping 120% over the past two years.

Driving the Massachusetts based company is a solid pipeline of drugs to treat multiple sclerosis. The firm also has a number of other therapies to treat diseases such as rheumatoid arthritis, lymphomas, Crohn’s disease, and psoriasis.

Tecfidera is Biogen Idec Inc. (NASDAQ:BIIB)’s new oral therapy recently approved in the U.S. for the treatment of relapsing forms of MS. The drug has been proven to significantly reduce important measures of the disease, including relapses and the development of brain lesions.

In addition, it is shown to slow disability progression over time.  Only on the market for a few months, Tecfidera sales have already surpassed even the loftiest expectations and are on pace to reach $800 million this year.

Biogen Idec Inc. (NASDAQ:BIIB)’s 2013 full year earnings are expected to grow 21.4%, with several analysts becoming more upbeat over the last few weeks. Consensus for this year’s cumulative earnings have risen to $7.66. Meanwhile, full 2014 consensus numbers have surged from $8.77 to $10.17.  Founded in 1978, Biogen Idec Inc. (NASDAQ:BIIB) is the world’s oldest independent biotechnology company and boasts more than $5 billion in annual revenue

The innovator

Celgene Corporation (NASDAQ:CELG), a global biopharmaceutical company with a market cap of $51 billion, is on a mission to deliver truly innovative and life changing drugs. There are more than 300 clinical trials at major medical centers using compounds from Celgene Corporation (NASDAQ:CELG) for the treatment of myriad cancers and rare blood diseases.

Shares have been on a tear, doubling over the last 12 months. Yet that hasn’t stopped a handful of analysts from further upgrading shares even at today’s levels.

Recently, Jefferies Group reaffirmed its “buy” rating and has a $152 price target. Cantor Fitzgerald and Guggenheim both reiterated “buy” ratings and $142 price targets. And, Argus raised its guidance from  to “buy” from “hold” and have a $140 price target on the stock.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!